What is the therapeutic efficacy of Sotorasib?

The therapeutic effect of Sotorasib is mainly reflected in its efficacy against KRAS G12C mutant non-small cell lung cancer (NSCLC). KRAS G12Cmutations are relatively common in a variety of cancers, and sotoracib, as an innovative anti-cancer drug, provides a targeted treatment plan for this specific genetic mutation.

In clinical trials, sotoraxib has shown some efficacy in the treatment of KRAS G12Cmutated non-small cell lung cancer. Research results show that some patients have significantly inhibited tumor growth after receiving sotoraxib treatment, and some even experienced tumor shrinkage. This is a positive development for patients with previously difficult-to-treat KRAS G12C mutated non-small cell lung cancer.

The efficacy of sotoracib has attracted attention from the medical community becauseKRAS G12C mutant has long been considered difficult to effectively intervene. The emergence of this drug provides a new treatment direction for cancers caused by this specific gene mutation, filling some of the gaps in previous treatments.

However, it is important to note that the effectiveness of medications may vary from individual to individual and is still being continuously studied and monitored. The long-term sustainability of treatment effects and overall patient survival require more time and research to verify. Patients should closely follow their doctor's instructions when using sotoraxib and conduct regular testing and evaluation of efficacy to ensure the best treatment results.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.